Human Papillomavirus Vaccine Safety in Pediatric Patients: An Evaluation of the Vaccine Adverse Event Reporting System

被引：12
|
作者：
Borja-Hart, Nancy L. [1 ]
Benavides, Sandra [1 ]
Christensen, Crystal [1 ]
机构：
[1] Nova SE Univ, Coll Pharm, Ft Lauderdale, FL 33328 USA
来源：
ANNALS OF PHARMACOTHERAPY | 2009年 / 43卷 / 02期
关键词：
Gardasil; human papillomavirus; pediatrics; VAERS; PARTICLE VACCINE; QUADRIVALENT VACCINE; UNITED-STATES; TYPE-16; IMMUNOGENICITY; ADOLESCENTS; TRIAL; WOMEN;
D O I：
10.1345/aph.1L492
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Recent news reports have linked the human papillomavirus (HPV) vaccine to serious adverse events (AEs) in children and adolescents. We used the Vaccine Adverse Event Reporting System (VAERS) database to extract postmarketing AEs reported in patients who received the vaccine. Since approval of the HPV vaccine in the US, 3174 AEs occurring in children and adolescents (aged 6-17 y) have been reported to the VAERS. Of these, 191 (6%) were deemed to be serious. Although these AEs are of significant concern, more research is required before they can be directly correlated with the vaccine.
引用
收藏
页码：356 / 359
页数：4
相关论文
共 50 条
  • [1] Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017
    Suragh, Tiffany A.
    Lewis, Paige
    Arana, Jorge
    Mba-Jonas, Adamma
    Li, Rongxia
    Stewart, Brock
    Shimabukuro, Tom T.
    Cano, Maria
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (12) : 2928 - 2932
  • [2] Trends in Human Papillomavirus Vaccine Safety Concerns and Adverse Event Reporting in the United States
    Sonawane, Kalyani
    Lin, Yueh-Yun
    Damgacioglu, Haluk
    Zhu, Yenan
    Fernandez, Maria E.
    Montealegre, Jane R.
    Cazaban, Cecilia Ganduglia
    Li, Ruosha
    Lairson, David R.
    Lin, Ying
    Giuliano, Anna R.
    Deshmukh, Ashish A.
    JAMA NETWORK OPEN, 2021, 4 (09)
  • [3] Postmarketing Safety Surveillance of a Hexavalent Vaccine in the Vaccine Adverse Event Reporting System
    Moro, Pedro L.
    Zhang, Bicheng
    Marquez, Paige
    Reich, Jonathan
    JOURNAL OF PEDIATRICS, 2023, 262
  • [4] The vaccine adverse event reporting system and vaccine safety research in the genomics era
    Davis, Robert Lowell
    VACCINE, 2012, 30 (06) : 1162 - 1164
  • [5] The role of the vaccine adverse event reporting system (VAERS) in monitoring vaccine safety
    Iskander, JK
    Miller, ER
    Chen, RT
    PEDIATRIC ANNALS, 2004, 33 (09): : 599 - 606
  • [6] Understanding vaccine safety information from the vaccine adverse event reporting system
    Varricchio, F
    Iskander, J
    Destefano, F
    Ball, R
    Pless, R
    Braun, MM
    Chen, RT
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (04) : 287 - 294
  • [7] Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)
    Sever, JL
    Brenner, AI
    Gale, AD
    Lyle, JM
    Moulton, LH
    Ward, BJ
    West, DJ
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (12) : 825 - 840
  • [8] Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015
    Arana, Jorge E.
    Harrington, Theresa
    Cano, Maria
    Lewis, Paige
    Mba-Jonas, Adamma
    Li Rongxia
    Stewart, Brock
    Markowitz, Lauri E.
    Shimabukuro, Tom T.
    VACCINE, 2018, 36 (13) : 1781 - 1788
  • [9] Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
    Shimabukuro, Tom T.
    Nguyen, Michael
    Martin, David
    DeStefano, Frank
    VACCINE, 2015, 33 (36) : 4398 - 4405
  • [10] The Vaccine Adverse Event Reporting System
    Varricchio, F
    JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1998, 36 (07): : 765 - 768
12345